Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fractional CO2 laser-assisted betamethasone versus 5-fluorouracil for nail psoriasis
PACTR202603828332085Completed
- Sponsor
- Mohamed Zaky
- Start
- Jan 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of betamethasone dipropionate and fluorouracil in nail psoriasis (2 arms), sponsored by Mohamed Zaky. Primary endpoint: Change in total Nail Psoriasis Severity Index from baseline. Started Jan 2024; status: completed.
02
Drugs
betamethasone dipropionatefluorouracil
03
Conditions
nail psoriasis
Beyond the preview
Go deeper on PACTR202603828332085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202603828332085.